Predictors of response to neoadjuvant checkpoint inhibition with chemotherapy in triple-negative breast cancer (TNBC): A meta-analysis of randomized control trials (RCTs)

被引：0
|
作者：
Roy, A. M. [1 ]
Attwood, K. [2 ]
Gandhi, S. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Med Oncol Hematol, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.03.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158P
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] Platinum-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
    Poggio, Francesca
    Bruzzone, Marco
    Ceppi, Marcello
    Ponde, Noam Falbel
    La Valle, Giovanni
    Sotiriou, Christos
    Del Mastro, Lucia
    De Azambuja, Evandro
    Lambertini, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
    Zhang, Wei
    Li, Emma
    Wang, Lily
    Lehmann, Brian D. D.
    Chen, X. Steven
    CANCERS, 2023, 15 (08)
  • [3] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Alcantara, M. J. E.
    Ordinario, M. V.
    Li, R. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1245 - S1246
  • [4] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Ordinario, M. V. C.
    Alcantara, M. J. E.
    Li, R. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S320 - S320
  • [5] Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
    Li, Yunhai
    Xing, Lei
    Li, Fan
    Liu, Hong
    Gan, Lu
    Yang, Dejuan
    Wang, Mengxue
    Yin, Xuedong
    Li, Hongyuan
    Ren, Guosheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [7] A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer
    Li, Y.
    Xing, L.
    Yin, X.
    Li, H.
    Ren, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S50 - S51
  • [8] Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
    Levee, Alexis
    Wong, Megan
    Flores, Sarah
    Ruel, Nora H.
    Lavasani, Sayeh Moazami
    Patel, Niki
    Sedrak, Mina S.
    Stewart, Daphne B.
    Waisman, James Ross
    Yuan, Yuan
    Mortimer, Joanne E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
    Yu, Y.
    Zhang, J.
    Lin, Y.
    Kang, S.
    Lv, X.
    Song, C.
    BREAST, 2021, 56 : S50 - S50
12345